North China Pharmaceutical Company.Ltd Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Xin Yan Liu
Chief executive officer
CN¥262.4k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Benign Growth For North China Pharmaceutical Company.Ltd (SHSE:600812) Underpins Its Share Price
Sep 25
North China Pharmaceutical Company.Ltd's (SHSE:600812) Profits Appear To Have Quality Issues
Aug 20The Market Doesn't Like What It Sees From North China Pharmaceutical Company.Ltd's (SHSE:600812) Revenues Yet
Apr 26CEO
Xin Yan Liu (54 yo)
3.3yrs
Tenure
CN¥262,400
Compensation
Mr. Xin Yan Liu is General Manager and Director of North China Pharmaceutical Company Ltd. since August 13, 2021 and served as its Deputy General Manager.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 3.3yrs | CN¥262.40k | no data | |
| CFO & Chief Accountant | 3.3yrs | CN¥200.40k | no data | |
| Deputy GM & Secretary | 8.7yrs | CN¥200.40k | no data |
3.3yrs
Average Tenure
53yo
Average Age
Experienced Management: 600812's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 3.3yrs | CN¥262.40k | no data | |
| Independent Director | 5.5yrs | CN¥71.40k | no data | |
| Independent Director | 5.5yrs | CN¥71.40k | no data | |
| Director | 6.2yrs | CN¥200.40k | no data | |
| Supervisor | 6.2yrs | no data | no data | |
| Independent Director | 3.6yrs | CN¥71.40k | no data | |
| Independent Director | 5.5yrs | CN¥71.40k | no data | |
| Director | 1.7yrs | no data | no data | |
| Chairman of the Supervisory Board | 2.1yrs | no data | no data | |
| Supervisor | 2.1yrs | no data | no data |
4.5yrs
Average Tenure
55yo
Average Age
Experienced Board: 600812's board of directors are considered experienced (4.5 years average tenure).